Item Type | Name |
Concept
|
Antipsychotic Agents
|
Concept
|
Codon, Terminator
|
Concept
|
Adaptor Proteins, Signal Transducing
|
Concept
|
Gemfibrozil
|
Concept
|
Congenital Hypothyroidism
|
Concept
|
Electrophoresis, Polyacrylamide Gel
|
Concept
|
Respiratory Function Tests
|
Concept
|
G(M1) Ganglioside
|
Concept
|
Lymphocytes
|
Concept
|
Reflex, Startle
|
Concept
|
Longitudinal Studies
|
Concept
|
Colforsin
|
Concept
|
Inclusion Bodies
|
Concept
|
Enkephalin, Leucine
|
Concept
|
Odds Ratio
|
Concept
|
Cerebral Amyloid Angiopathy
|
Concept
|
Chromosomes, Human, X
|
Concept
|
Primary Ovarian Insufficiency
|
Concept
|
White Matter
|
Concept
|
Prenatal Diagnosis
|
Concept
|
Parents
|
Concept
|
Fatal Outcome
|
Concept
|
Cholera Toxin
|
Concept
|
Health Services Needs and Demand
|
Concept
|
Synapses
|
Concept
|
Dendritic Spines
|
Concept
|
Checklist
|
Concept
|
Genomic Instability
|
Concept
|
Alprostadil
|
Concept
|
Piperazines
|
Concept
|
Enzyme-Linked Immunosorbent Assay
|
Concept
|
Receptors, AMPA
|
Concept
|
Age Factors
|
Concept
|
Acoustic Stimulation
|
Concept
|
Karyotyping
|
Concept
|
Disease Models, Animal
|
Concept
|
Fibroblasts
|
Concept
|
Precision Medicine
|
Concept
|
DNA Methylation
|
Concept
|
Diagnosis, Computer-Assisted
|
Concept
|
Health Surveys
|
Concept
|
Narcotics
|
Concept
|
Sequence Analysis, DNA
|
Concept
|
Speech
|
Concept
|
Cations
|
Concept
|
PPAR alpha
|
Concept
|
Databases, Factual
|
Concept
|
Sandhoff Disease
|
Concept
|
Electrocardiography, Ambulatory
|
Concept
|
Brain Diseases, Metabolic, Inborn
|
Concept
|
Body Height
|
Concept
|
Matrix Attachment Region Binding Proteins
|
Concept
|
Amyloid beta-Protein Precursor
|
Concept
|
Genetic Linkage
|
Concept
|
Gene Amplification
|
Concept
|
Hydroxycholesterols
|
Concept
|
Hybrid Cells
|
Concept
|
Central Nervous System Stimulants
|
Concept
|
Biological Specimen Banks
|
Concept
|
Guidelines as Topic
|
Concept
|
Blood Pressure
|
Concept
|
Calcimycin
|
Concept
|
Protein Processing, Post-Translational
|
Concept
|
Genetic Association Studies
|
Concept
|
Cerebral Infarction
|
Concept
|
Cell Lineage
|
Concept
|
Nicotine
|
Concept
|
Monitoring, Ambulatory
|
Concept
|
Pyridines
|
Concept
|
Pilot Projects
|
Concept
|
Hexosaminidase A
|
Concept
|
Mutation
|
Concept
|
Computers
|
Concept
|
Humans
|
Concept
|
Fragile X Mental Retardation Protein
|
Concept
|
Urinary Incontinence
|
Concept
|
Likelihood Functions
|
Concept
|
Homeodomain Proteins
|
Concept
|
Pedigree
|
Concept
|
Organ Size
|
Concept
|
Membrane Glycoproteins
|
Concept
|
Parent-Child Relations
|
Concept
|
Cerebellum
|
Concept
|
Receptors, GABA
|
Concept
|
Down-Regulation
|
Concept
|
Gait
|
Concept
|
Chicago
|
Concept
|
Mothers
|
Concept
|
Caregivers
|
Concept
|
Food, Formulated
|
Concept
|
Disability Evaluation
|
Concept
|
Long QT Syndrome
|
Concept
|
Chromosomes, Human, Pair 16
|
Concept
|
Heredodegenerative Disorders, Nervous System
|
Concept
|
Drug Eruptions
|
Concept
|
Restriction Mapping
|
Concept
|
Multigene Family
|
Concept
|
Mitochondria
|
Concept
|
DiGeorge Syndrome
|
Concept
|
Cognitive Dysfunction
|
Concept
|
Spatio-Temporal Analysis
|
Concept
|
Foot
|
Concept
|
Fecal Incontinence
|
Concept
|
Dioxoles
|
Concept
|
Incidence
|
Concept
|
Introns
|
Concept
|
Proportional Hazards Models
|
Concept
|
Glutamic Acid
|
Concept
|
Heterozygote
|
Concept
|
Recurrence
|
Concept
|
Optic Disk
|
Concept
|
2-Chloroadenosine
|
Concept
|
Genetic Therapy
|
Concept
|
Embryo, Mammalian
|
Concept
|
Enkephalin, Leucine-2-Alanine
|
Concept
|
Cytosine
|
Concept
|
Neurologic Examination
|
Concept
|
Diagnostic Techniques, Neurological
|
Concept
|
Neurofilament Proteins
|
Concept
|
Deoxyribonucleases, Type II Site-Specific
|
Concept
|
Magnetic Resonance Imaging
|
Concept
|
Movement Disorders
|
Concept
|
Age of Onset
|
Concept
|
Cross-Over Studies
|
Concept
|
Basal Ganglia
|
Concept
|
Sex Distribution
|
Concept
|
Phospholipase D
|
Concept
|
Gene Expression
|
Concept
|
Trisomy
|
Concept
|
Receptors, Dopamine
|
Concept
|
Hair
|
Concept
|
Drosophila melanogaster
|
Concept
|
Neurturin
|
Concept
|
Depression
|
Concept
|
Lysosomes
|
Concept
|
Neurogenesis
|
Concept
|
Dosage Compensation, Genetic
|
Concept
|
Protein Biosynthesis
|
Concept
|
Confidence Intervals
|
Concept
|
Genetic Testing
|
Concept
|
Demography
|
Concept
|
Health Status
|
Concept
|
Synaptic Transmission
|
Concept
|
Algorithms
|
Concept
|
Adrenergic beta-Antagonists
|
Concept
|
Mice, Knockout
|
Concept
|
Minisatellite Repeats
|
Concept
|
Menopause
|
Concept
|
Adenosine Triphosphate
|
Concept
|
Feasibility Studies
|
Concept
|
Amino Acid Sequence
|
Concept
|
Binding, Competitive
|
Concept
|
Blood Cell Count
|
Concept
|
Monitoring, Physiologic
|
Concept
|
Facial Expression
|
Concept
|
PPAR-beta
|
Concept
|
Epidemiologic Studies
|
Concept
|
Spinal Puncture
|
Concept
|
Double-Blind Method
|
Concept
|
Georgia
|
Concept
|
Chronic Disease
|
Concept
|
Random Allocation
|
Concept
|
Vitamin E
|
Concept
|
Methylation
|
Concept
|
Child Development
|
Concept
|
Amino Acid Substitution
|
Concept
|
Patient Acceptance of Health Care
|
Concept
|
Child Nutritional Physiological Phenomena
|
Concept
|
Glial Fibrillary Acidic Protein
|
Concept
|
Syndrome
|
Concept
|
Corpus Callosum
|
Concept
|
Receptor, Serotonin, 5-HT2A
|
Concept
|
Golgi Apparatus
|
Concept
|
Macrophages
|
Concept
|
National Institutes of Health (U.S.)
|
Concept
|
Fragile X Syndrome
|
Concept
|
Genes, Dominant
|
Concept
|
Serotonin
|
Concept
|
Tretinoin
|
Concept
|
Cyclodextrins
|
Concept
|
Sudden Infant Death
|
Concept
|
Cricetinae
|
Concept
|
Rett Syndrome
|
Concept
|
Comprehension
|
Concept
|
Epilepsy, Rolandic
|
Concept
|
Zinc
|
Concept
|
Arrhythmia, Sinus
|
Concept
|
Mental Retardation, X-Linked
|
Concept
|
Microsatellite Repeats
|
Concept
|
Pituitary Adenylate Cyclase-Activating Polypeptide
|
Concept
|
Down Syndrome
|
Concept
|
Angelman Syndrome
|
Concept
|
Neuronal Ceroid-Lipofuscinoses
|
Concept
|
Hirschsprung Disease
|
Concept
|
Cell Membrane
|
Concept
|
Nuclear Family
|
Concept
|
Epigenesis, Genetic
|
Concept
|
Quality-Adjusted Life Years
|
Concept
|
Language Tests
|
Concept
|
Sex Factors
|
Concept
|
Trinucleotide Repeat Expansion
|
Concept
|
ras Proteins
|
Concept
|
Respiration, Artificial
|
Concept
|
G(M2) Ganglioside
|
Concept
|
Gene Knock-In Techniques
|
Concept
|
Neuroimaging
|
Concept
|
Reverse Transcriptase Polymerase Chain Reaction
|
Concept
|
Thymus Gland
|
Concept
|
Population Surveillance
|
Concept
|
Molecular Diagnostic Techniques
|
Concept
|
Models, Genetic
|
Concept
|
Aminopeptidases
|
Concept
|
Metabolomics
|
Concept
|
Click Chemistry
|
Concept
|
Self Report
|
Concept
|
Antioxidants
|
Concept
|
Niemann-Pick Disease, Type A
|
Concept
|
Anesthetics
|
Concept
|
Cytochrome P-450 CYP1A1
|
Concept
|
Early Medical Intervention
|
Concept
|
Clone Cells
|
Concept
|
Genetic Carrier Screening
|
Concept
|
Serine Proteases
|
Concept
|
Interdisciplinary Communication
|
Concept
|
Alzheimer Disease
|
Concept
|
Evoked Potentials, Auditory
|
Concept
|
alpha-Fetoproteins
|
Concept
|
Glycosylphosphatidylinositols
|
Concept
|
Genome, Human
|
Concept
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors
|
Concept
|
Genetic Counseling
|
Concept
|
Mass Screening
|
Concept
|
Genotype
|
Concept
|
Levodopa
|
Concept
|
Infant Nutritional Physiological Phenomena
|
Concept
|
Polymorphism, Genetic
|
Concept
|
Ehlers-Danlos Syndrome
|
Concept
|
California
|
Concept
|
Polymorphism, Single-Stranded Conformational
|
Concept
|
Administration, Oral
|
Concept
|
Hypothalamic Diseases
|
Concept
|
Rare Diseases
|
Concept
|
Infusions, Intraventricular
|
Concept
|
Imidazoles
|
Concept
|
Fluorescent Antibody Technique
|
Concept
|
Mitochondrial Membranes
|
Concept
|
Cyclic Nucleotide Phosphodiesterases, Type 4
|
Concept
|
Cholinesterase Inhibitors
|
Concept
|
Hyperkinesis
|
Concept
|
Disease Progression
|
Concept
|
Dependovirus
|
Concept
|
Practice Guidelines as Topic
|
Concept
|
Catecholamines
|
Concept
|
Fathers
|
Concept
|
Transcriptome
|
Concept
|
Long-Term Potentiation
|
Concept
|
Creatine
|
Concept
|
Pupil
|
Concept
|
Body Weight
|
Concept
|
Fingers
|
Concept
|
Treatment Outcome
|
Concept
|
Health Knowledge, Attitudes, Practice
|
Concept
|
Mice, Inbred BALB C
|
Concept
|
Sensitivity and Specificity
|
Concept
|
Focus Groups
|
Concept
|
Genitalia
|
Concept
|
Autophagy
|
Concept
|
Sialic Acid Binding Ig-like Lectin 2
|
Concept
|
Dietary Fats
|
Concept
|
Infusions, Spinal
|
Concept
|
Gene Rearrangement
|
Concept
|
Trinucleotide Repeats
|
Concept
|
Cats
|
Concept
|
Prostaglandins E
|
Concept
|
DNA, Complementary
|
Concept
|
Registries
|
Concept
|
Polymorphism, Single Nucleotide
|
Concept
|
Cohort Studies
|
Concept
|
Antibodies
|
Concept
|
Influenza, Human
|
Concept
|
DNA, Mitochondrial
|
Concept
|
Ubiquitin Thiolesterase
|
Concept
|
Databases, Genetic
|
Concept
|
Cerebral Ventricles
|
Concept
|
Germ Cells
|
Concept
|
Stroke
|
Concept
|
Attitude to Health
|
Concept
|
Electromyography
|
Concept
|
Death, Sudden
|
Concept
|
Calcium
|
Concept
|
Adenylyl Cyclases
|
Concept
|
Chromosomes, Human, Pair 4
|
Concept
|
Hydrogen Peroxide
|
Concept
|
Breath Holding
|
Concept
|
Signal Processing, Computer-Assisted
|
Concept
|
Guanine
|
Concept
|
CHO Cells
|
Concept
|
Blotting, Western
|
Concept
|
Tuberous Sclerosis
|
Concept
|
Injections, Spinal
|
Concept
|
Cerebellar Ataxia
|
Concept
|
Ascorbic Acid
|
Concept
|
Radiography
|
Concept
|
Medical History Taking
|
Concept
|
Atrophy
|
Concept
|
Tunicamycin
|
Concept
|
Dementia
|
Concept
|
High-Throughput Nucleotide Sequencing
|
Concept
|
Dental Care
|
Concept
|
Polysomnography
|
Concept
|
Ataxia
|
Concept
|
Prevalence
|
Concept
|
Case-Control Studies
|
Concept
|
Lewy Body Disease
|
Concept
|
Baroreflex
|
Concept
|
beta-N-Acetylhexosaminidases
|
Concept
|
Gait Ataxia
|
Concept
|
Microfilament Proteins
|
Concept
|
Hexosaminidase B
|
Concept
|
Extracellular Signal-Regulated MAP Kinases
|
Concept
|
Predictive Value of Tests
|
Concept
|
Reproducibility of Results
|
Concept
|
Respiratory Rate
|
Concept
|
Ovary
|
Concept
|
Diseases in Twins
|
Concept
|
New York
|
Concept
|
Nutritional Requirements
|
Concept
|
Hypothalamo-Hypophyseal System
|
Concept
|
Prospective Studies
|
Concept
|
Phosphodiesterase 4 Inhibitors
|
Concept
|
Electron Transport
|
Concept
|
Reflex, Pupillary
|
Concept
|
3' Untranslated Regions
|
Concept
|
Paroxetine
|
Concept
|
Cross-Sectional Studies
|
Concept
|
Rats
|
Concept
|
Amniocentesis
|
Concept
|
Growth
|
Concept
|
Limit of Detection
|
Concept
|
Hexokinase
|
Concept
|
Least-Squares Analysis
|
Concept
|
Niemann-Pick Disease, Type C
|
Concept
|
PPAR gamma
|
Concept
|
Epilepsies, Partial
|
Concept
|
Cutis Laxa
|
Concept
|
Staining and Labeling
|
Concept
|
Codon, Nonsense
|
Concept
|
In Situ Hybridization
|
Concept
|
Randomized Controlled Trials as Topic
|
Concept
|
Tremor
|
Concept
|
Type C Phospholipases
|
Concept
|
Lysergic Acid
|
Concept
|
Agenesis of Corpus Callosum
|
Concept
|
Brain Waves
|
Concept
|
Genome-Wide Association Study
|
Concept
|
Immunization
|
Concept
|
Ganglioneuroblastoma
|
Concept
|
Cytidine Diphosphate Choline
|
Concept
|
Enzyme Replacement Therapy
|
Concept
|
Chromosome Aberrations
|
Concept
|
Tyrosine 3-Monooxygenase
|
Concept
|
Proteomics
|
Concept
|
Embryo, Nonmammalian
|
Concept
|
Surveys and Questionnaires
|
Concept
|
Pantothenate Kinase-Associated Neurodegeneration
|
Concept
|
Enzyme Inhibitors
|
Concept
|
Peptide Hydrolases
|
Concept
|
Neural Inhibition
|
Concept
|
Cell Line
|
Concept
|
Risperidone
|
Concept
|
Myotonic Dystrophy
|
Concept
|
Walking
|
Concept
|
Hallucinations
|
Concept
|
Chromosome Deletion
|
Concept
|
Oligonucleotide Array Sequence Analysis
|
Concept
|
Regression Analysis
|
Concept
|
Dried Blood Spot Testing
|
Concept
|
Asymptomatic Diseases
|
Concept
|
Lipopolysaccharides
|
Concept
|
Exome
|
Concept
|
Translocation, Genetic
|
Concept
|
Cricetulus
|
Concept
|
Anti-Inflammatory Agents, Non-Steroidal
|
Concept
|
Hydrocortisone
|
Concept
|
Heart Defects, Congenital
|
Concept
|
Dietary Carbohydrates
|
Concept
|
Genetic Predisposition to Disease
|
Concept
|
Filamins
|
Concept
|
Tumor Cells, Cultured
|
Concept
|
Glioma
|
Concept
|
Iron
|
Concept
|
Infant Formula
|
Concept
|
Parkinsonian Disorders
|
Concept
|
Early Diagnosis
|
Concept
|
Obesity
|
Concept
|
Logistic Models
|
Concept
|
Dystonia
|
Concept
|
Protein Synthesis Inhibitors
|
Concept
|
Leukoencephalopathies
|
Concept
|
Radioimmunoassay
|
Concept
|
Mice
|
Concept
|
Language
|
Concept
|
Forecasting
|
Concept
|
Arrhythmias, Cardiac
|
Concept
|
Clinical Trials as Topic
|
Concept
|
Haploinsufficiency
|
Concept
|
Aging
|
Concept
|
DNA Primers
|
Concept
|
Excitatory Amino Acid Antagonists
|
Concept
|
Receptors, Metabotropic Glutamate
|
Concept
|
Endopeptidases
|
Concept
|
Factor Analysis, Statistical
|
Concept
|
Genetic Variation
|
Concept
|
Baclofen
|
Concept
|
Immunoenzyme Techniques
|
Concept
|
Epilepsy
|
Concept
|
Plasma Membrane Neurotransmitter Transport Proteins
|
Concept
|
Statistics, Nonparametric
|
Concept
|
Michigan
|
Concept
|
Hearing Loss, High-Frequency
|
Concept
|
Real-Time Polymerase Chain Reaction
|
Concept
|
Kinetics
|
Concept
|
Drug Evaluation, Preclinical
|
Concept
|
Intermediate Filaments
|
Concept
|
Pyrimidinones
|
Concept
|
Linear Models
|
Concept
|
Range of Motion, Articular
|
Concept
|
Epilepsies, Myoclonic
|
Concept
|
Primary Cell Culture
|
Concept
|
Transfection
|
Concept
|
Point Mutation
|
Concept
|
Gene Frequency
|
Concept
|
Clonidine
|
Concept
|
Databases as Topic
|
Concept
|
Polymerase Chain Reaction
|
Concept
|
Apomorphine
|
Concept
|
Cerebellar Cortex
|
Concept
|
Hippocampus
|
Concept
|
Piperidines
|
Concept
|
Morpholines
|
Concept
|
Hypoglycemia
|
Concept
|
Corpus Striatum
|
Concept
|
Fixation, Ocular
|
Concept
|
Vaccination
|
Concept
|
Parkinson Disease
|
Concept
|
United States Food and Drug Administration
|
Concept
|
Gene Deletion
|
Concept
|
Cholesterol
|
Concept
|
Risk Assessment
|
Concept
|
In Situ Hybridization, Fluorescence
|
Concept
|
Delivery of Health Care
|
Concept
|
Genetic Vectors
|
Concept
|
Mutation, Missense
|
Concept
|
Risk
|
Concept
|
Gangliosides
|
Concept
|
Deglutition
|
Concept
|
Hydrogen-Ion Concentration
|
Concept
|
Risk Factors
|
Concept
|
Signal-To-Noise Ratio
|
Concept
|
Weight Gain
|
Concept
|
Cerebellar Diseases
|
Concept
|
Promoter Regions, Genetic
|
Concept
|
Gels
|
Concept
|
Gene Silencing
|
Concept
|
Apolipoprotein E2
|
Concept
|
Gene Duplication
|
Concept
|
Enkephalins
|
Concept
|
Receptors, Opioid, delta
|
Concept
|
Cyclic AMP
|
Concept
|
Base Sequence
|
Concept
|
Alleles
|
Concept
|
Follow-Up Studies
|
Concept
|
Carbidopa
|
Concept
|
Autopsy
|
Concept
|
Zebrafish
|
Concept
|
Diffusion Tensor Imaging
|
Concept
|
Amyloid beta-Peptides
|
Concept
|
Genes, Homeobox
|
Concept
|
Siblings
|
Concept
|
Heart Diseases
|
Concept
|
Glial Cell Line-Derived Neurotrophic Factor Receptors
|
Concept
|
Immunohistochemistry
|
Concept
|
Comorbidity
|
Concept
|
ROC Curve
|
Concept
|
Gene Transfer Techniques
|
Concept
|
Mice, Mutant Strains
|
Concept
|
Frameshift Mutation
|
Concept
|
Brain-Derived Neurotrophic Factor
|
Concept
|
Molecular Sequence Data
|
Concept
|
X Chromosome
|
Concept
|
Heart Function Tests
|
Concept
|
Prostaglandins
|
Concept
|
Gene Expression Regulation, Developmental
|
Concept
|
Electroencephalography
|
Concept
|
Haplotypes
|
Concept
|
Mitral Valve Prolapse
|
Concept
|
Dopamine
|
Concept
|
Proton-Translocating ATPases
|
Concept
|
Eye Movements
|
Concept
|
Exons
|
Concept
|
Cerebral Cortex
|
Concept
|
Treatment Failure
|
Concept
|
Mutagenesis, Insertional
|
Concept
|
Glucosamine
|
Concept
|
Embryonic and Fetal Development
|
Concept
|
Videotape Recording
|
Concept
|
Mice, Inbred C57BL
|
Concept
|
Chromosomes, Human, Pair 9
|
Concept
|
Diagnostic and Statistical Manual of Mental Disorders
|
Concept
|
Mosaicism
|
Concept
|
Ganglioneuroma
|
Concept
|
Retrospective Studies
|
Concept
|
Repetitive Sequences, Nucleic Acid
|
Concept
|
Dipeptidyl-Peptidases and Tripeptidyl-Peptidases
|
Concept
|
Gene Expression Regulation
|
Concept
|
Glial Cell Line-Derived Neurotrophic Factors
|
Concept
|
Psychomotor Agitation
|
Concept
|
DNA Repeat Expansion
|
Concept
|
Platelet Count
|
Concept
|
Sequence Deletion
|
Concept
|
Neonatal Screening
|
Concept
|
Cells, Cultured
|
Concept
|
Brain Mapping
|
Concept
|
Academic Medical Centers
|
Concept
|
MEF2 Transcription Factors
|
Concept
|
Blood Platelets
|
Concept
|
Mice, Transgenic
|
Concept
|
Dermatoglyphics
|
Concept
|
Chromosome Disorders
|
Concept
|
Physicians
|
Concept
|
Pandemics
|
Concept
|
Class I Phosphatidylinositol 3-Kinases
|
Concept
|
Cycloaddition Reaction
|
Concept
|
Huntington Disease
|
Concept
|
Cholecystokinin
|
Concept
|
Phosphorylcholine
|
Concept
|
Zebrafish Proteins
|
Concept
|
Sinus Arrest, Cardiac
|
Concept
|
Biomechanical Phenomena
|
Concept
|
Decision Support Techniques
|
Concept
|
Receptor, Metabotropic Glutamate 5
|
Concept
|
Receptors, Cholecystokinin
|
Concept
|
Transforming Growth Factor beta1
|
Concept
|
Chromosomes, Human, Pair 22
|
Concept
|
Toilet Training
|
Concept
|
Serotonin Plasma Membrane Transport Proteins
|
Concept
|
Heart Rate
|
Concept
|
DNA Mutational Analysis
|
Concept
|
Orexin Receptors
|
Concept
|
Facies
|
Concept
|
Exercise
|
Concept
|
Epilepsy, Generalized
|
Concept
|
Bile Acids and Salts
|
Concept
|
Spiperone
|
Concept
|
Lithium Carbonate
|
Concept
|
Severity of Illness Index
|
Concept
|
Attention
|
Concept
|
Glutathione Transferase
|
Concept
|
Cell Proliferation
|
Concept
|
Alkynes
|
Concept
|
Gene Dosage
|
Concept
|
Diagnostic Errors
|
Concept
|
Glucose
|
Academic Article
|
Characterization and Early Detection of Balance Deficits in Fragile X Premutation Carriers With and Without Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS).
|
Academic Article
|
The apolipoprotein E epsilon4 allele and incident Alzheimer's disease in persons with mild cognitive impairment.
|
Academic Article
|
The apolipoprotein E epsilon 4 allele and decline in different cognitive systems during a 6-year period.
|
Academic Article
|
Apolipoprotein E epsilon4 allele, AD pathology, and the clinical expression of Alzheimer's disease.
|
Academic Article
|
Amyloid mediates the association of apolipoprotein E e4 allele to cognitive function in older people.
|
Academic Article
|
Fragile X gene expansions are not associated with dementia.
|
Academic Article
|
Intrastriatal CERE-120 (AAV-Neurturin) protects striatal and cortical neurons and delays motor deficits in a transgenic mouse model of Huntington's disease.
|
Academic Article
|
Viral delivery of glial cell line-derived neurotrophic factor improves behavior and protects striatal neurons in a mouse model of Huntington's disease.
|
Academic Article
|
The apolipoprotein E epsilon4 allele increases the odds of chronic cerebral infarction [corrected] detected at autopsy in older persons.
|
Academic Article
|
Incidence of Alzheimer disease in a biracial urban community: relation to apolipoprotein E allele status.
|
Academic Article
|
Fragile X-associated tremor/ataxia syndrome: clinical features, genetics, and testing guidelines.
|
Academic Article
|
Erratum: Emerging topics in FXTAS.
|
Academic Article
|
Genetic polymorphisms in Parkinson disease subjects with and without hallucinations: an analysis of the cholecystokinin system.
|
Academic Article
|
Treatment of fragile X-associated tremor ataxia syndrome (FXTAS) and related neurological problems.
|
Academic Article
|
Symptomatic treatment in the fragile X-associated tremor/ataxia syndrome.
|
Academic Article
|
Clinical features of neurodegeneration with brain iron accumulation due to a C19orf12 gene mutation.
|
Academic Article
|
Initial diagnoses given to persons with the fragile X associated tremor/ataxia syndrome (FXTAS).
|
Academic Article
|
Abnormal elevation of FMR1 mRNA is associated with psychological symptoms in individuals with the fragile X premutation.
|
Academic Article
|
Activation of peroxisome proliferator-activated receptor a induces lysosomal biogenesis in brain cells: implications for lysosomal storage disorders.
|
Academic Article
|
Racial differences may influence the role of cholecystokinin polymorphisms in Parkinson's disease hallucinations.
|
Academic Article
|
FMR1 gray-zone alleles: association with Parkinson's disease in women?
|
Academic Article
|
Gait and Functional Mobility Deficits in Fragile X-Associated Tremor/Ataxia Syndrome.
|
Academic Article
|
Clinical Phenotype of Adult Fragile X Gray Zone Allele Carriers: a Case Series.
|
Academic Article
|
Emerging topics in FXTAS.
|
Academic Article
|
Executive dysfunction in young FMR1 premutation carriers: forme fruste of FXTAS or new phenotype?
|
Academic Article
|
New NBIA subtype: genetic, clinical, pathologic, and radiographic features of MPAN.
|
Academic Article
|
X-inactivation in the clinical phenotype of fragile X premutation carrier sisters.
|
Academic Article
|
FMR1 CGG repeat length predicts motor dysfunction in premutation carriers.
|
Academic Article
|
Neuropathic features in fragile X premutation carriers.
|
Academic Article
|
Progression of tremor and ataxia in male carriers of the FMR1 premutation.
|
Academic Article
|
Penetrance of the fragile X-associated tremor/ataxia syndrome in a premutation carrier population.
|
Academic Article
|
New observations in the fragile X-associated tremor/ataxia syndrome (FXTAS) phenotype.
|
Academic Article
|
Implementation of a markerless motion analysis method to quantify hyperkinesis in males with fragile X syndrome.
|
Academic Article
|
Update on the Clinical, Radiographic, and Neurobehavioral Manifestations in FXTAS and FMR1 Premutation Carriers.
|
Academic Article
|
Association of the serotonin transporter gene with sudden infant death syndrome: a haplotype analysis.
|
Academic Article
|
Idiopathic congenital central hypoventilation syndrome: analysis of genes pertinent to early autonomic nervous system embryologic development and identification of mutations in PHOX2b.
|
Academic Article
|
Sudden infant death syndrome: case-control frequency differences at genes pertinent to early autonomic nervous system embryologic development.
|
Academic Article
|
Fragile X-associated tremor/ataxia syndrome in sisters related to X-inactivation.
|
Academic Article
|
Changes in growth and seizure reduction in children on the ketogenic diet as a treatment for intractable epilepsy.
|
Academic Article
|
Facial phenotype in children and young adults with PHOX2B-determined congenital central hypoventilation syndrome: quantitative pattern of dysmorphology.
|
Academic Article
|
Characterization of dermatoglyphics in PHOX2B-confirmed congenital central hypoventilation syndrome.
|
Academic Article
|
Effect of CX516, an AMPA-modulating compound, on cognition and behavior in fragile X syndrome: a controlled trial.
|
Academic Article
|
Congenital central hypoventilation syndrome: PHOX2B genotype determines risk for sudden death.
|
Academic Article
|
Fibroblast phenotype in male carriers of FMR1 premutation alleles.
|
Academic Article
|
Congenital central hypoventilation syndrome: neurocognitive functioning in school age children.
|
Academic Article
|
Feasibility, reproducibility, and clinical validity of the pediatric anxiety rating scale-revised for fragile X syndrome.
|
Academic Article
|
Cholesterol levels in fragile X syndrome.
|
Academic Article
|
Congenital Central Hypoventilation Syndrome: Neurocognition Already Reduced in Preschool-Aged Children.
|
Academic Article
|
Genetic variation analysis in parkinson disease patients with and without hallucinations: case-control study.
|
Academic Article
|
Sudden infant death syndrome: association with a promoter polymorphism of the serotonin transporter gene.
|
Academic Article
|
Tremor and ataxia in fragile X premutation carriers: blinded videotape study.
|
Academic Article
|
The apolipoprotein E epsilon 2 allele and decline in episodic memory.
|
Academic Article
|
A methylation PCR method determines FMR1 activation ratios and differentiates premutation allele mosaicism in carrier siblings.
|
Academic Article
|
Fragile X syndrome and fragile X-associated tremor ataxia syndrome.
|
Academic Article
|
Drug development for neurodevelopmental disorders: lessons learned from fragile X syndrome.
|
Academic Article
|
Mutations in GPAA1, Encoding a GPI Transamidase Complex Protein, Cause Developmental Delay, Epilepsy, Cerebellar Atrophy, and Osteopenia.
|
Academic Article
|
Fragile X syndrome.
|
Academic Article
|
Effect of the mGluR5-NAM Basimglurant on Behavior in Adolescents and Adults with Fragile X Syndrome in a Randomized, Double-Blind, Placebo-Controlled Trial: FragXis Phase 2 Results.
|
Academic Article
|
Fragile X Newborn Screening: Lessons Learned From a Multisite Screening Study.
|
Academic Article
|
Autism Spectrum Disorder in Fragile X Syndrome: Cooccurring Conditions and Current Treatment.
|
Academic Article
|
FORWARD: A Registry and Longitudinal Clinical Database to Study Fragile X Syndrome.
|
Academic Article
|
The Future of Fragile X Syndrome: CDC Stakeholder Meeting Summary.
|
Academic Article
|
Intrathecal 2-hydroxypropyl-?-cyclodextrin decreases neurological disease progression in Niemann-Pick disease, type C1: a non-randomised, open-label, phase 1-2 trial.
|
Academic Article
|
Updated report on tools to measure outcomes of clinical trials in fragile X syndrome.
|
Academic Article
|
Fragile X targeted pharmacotherapy: lessons learned and future directions.
|
Academic Article
|
Arbaclofen in fragile X syndrome: results of phase 3 trials.
|
Academic Article
|
Erratum to: A developmental, longitudinal investigation of autism phenotypic profiles in fragile X syndrome.
|
Academic Article
|
A developmental, longitudinal investigation of autism phenotypic profiles in fragile X syndrome.
|
Academic Article
|
Developmental profiles of infants with an FMR1 premutation.
|
Academic Article
|
Treatment of Neurogenetic Developmental Conditions: From 2016 into the Future.
|
Academic Article
|
Importance of a specialty clinic for individuals with fragile X syndrome.
|
Academic Article
|
Clinicians' experiences with the fragile X clinical and research consortium.
|
Academic Article
|
The NIH Toolbox Cognitive Battery for intellectual disabilities: three preliminary studies and future directions.
|
Academic Article
|
Development of a bile acid-based newborn screen for Niemann-Pick disease type C.
|
Academic Article
|
Mavoglurant in adolescents with fragile X syndrome: analysis of Clinical Global Impression-Improvement source data from a double-blind therapeutic study followed by an open-label, long-term extension study.
|
Academic Article
|
Mavoglurant in fragile X syndrome: Results of two randomized, double-blind, placebo-controlled trials.
|
Academic Article
|
Cognitive trajectories in rare neurogenetic diseases: minding the gaps and filling the potholes.
|
Academic Article
|
Absence of mutations in HCRT, HCRTR1 and HCRTR2 in patients with ROHHAD.
|
Academic Article
|
Rapid-Onset Obesity with Hypothalamic Dysfunction, Hypoventilation, and Autonomic Dysregulation (ROHHAD): exome sequencing of trios, monozygotic twins and tumours.
|
Academic Article
|
Maternal Consequences of the Detection of Fragile X Carriers in Newborn Screening.
|
Academic Article
|
Therapeutic Strategies in Fragile X Syndrome: From Bench to Bedside and Back.
|
Academic Article
|
White matter disease and cognitive impairment in FMR1 premutation carriers.
|
Academic Article
|
Distribution of AGG interruption patterns within nine world populations.
|
Academic Article
|
Fragile X syndrome: a review of associated medical problems.
|
Academic Article
|
Autism and fragile X syndrome.
|
Academic Article
|
AGG interruptions and maternal age affect FMR1 CGG repeat allele stability during transmission.
|
Academic Article
|
Associated features in females with an FMR1 premutation.
|
Academic Article
|
Developing a utility index for the Aberrant Behavior Checklist (ABC-C) for fragile X syndrome.
|
Academic Article
|
Climbing the branches of a family tree: diagnosis of fragile X syndrome.
|
Academic Article
|
Mechanism-based treatments in neurodevelopmental disorders: fragile X syndrome.
|
Academic Article
|
Improving IQ measurement in intellectual disabilities using true deviation from population norms.
|
Academic Article
|
Development of mavoglurant and its potential for the treatment of fragile X syndrome.
|
Academic Article
|
The challenges of clinical trials in fragile X syndrome.
|
Academic Article
|
Outcome measures for clinical trials in fragile X syndrome.
|
Academic Article
|
Analysis of PAC1 receptor gene variants in Caucasian and African American infants dying of sudden infant death syndrome.
|
Academic Article
|
Developing BACE-1 inhibitors for FXS.
|
Academic Article
|
Development of a genomic DNA reference material panel for myotonic dystrophy type 1 (DM1) genetic testing.
|
Academic Article
|
Development of an expressive language sampling procedure in fragile X syndrome: a pilot study.
|
Academic Article
|
CDKL5 and ARX mutations in males with early-onset epilepsy.
|
Academic Article
|
Fragile X AGG analysis provides new risk predictions for 45-69 repeat alleles.
|
Academic Article
|
MEF2C Haploinsufficiency features consistent hyperkinesis, variable epilepsy, and has a role in dorsal and ventral neuronal developmental pathways.
|
Academic Article
|
FMR1 CGG allele size and prevalence ascertained through newborn screening in the United States.
|
Academic Article
|
Newborn, carrier, and early childhood screening recommendations for fragile X.
|
Academic Article
|
A triple threat: Down syndrome, congenital central hypoventilation syndrome, and Hirschsprung disease.
|
Academic Article
|
Effects of STX209 (arbaclofen) on neurobehavioral function in children and adults with fragile X syndrome: a randomized, controlled, phase 2 trial.
|
Academic Article
|
Feasibility, reliability, and clinical validity of the Test of Attentional Performance for Children (KiTAP) in Fragile X syndrome (FXS).
|
Academic Article
|
Clinic-based retrospective analysis of psychopharmacology for behavior in fragile x syndrome.
|
Academic Article
|
Congenital central hypoventilation syndrome with PHOX2B gene mutation: are we missing the diagnosis?
|
Academic Article
|
Germline mosaicism of PHOX2B mutation accounts for familial recurrence of congenital central hypoventilation syndrome (CCHS).
|
Academic Article
|
Medication utilization for targeted symptoms in children and adults with fragile X syndrome: US survey.
|
Academic Article
|
Reversal of fragile X phenotypes by manipulation of A?PP/A? levels in Fmr1KO mice.
|
Academic Article
|
Fragile X syndrome and targeted treatment trials.
|
Academic Article
|
Psychometric study of the Aberrant Behavior Checklist in Fragile X Syndrome and implications for targeted treatment.
|
Academic Article
|
Variable human phenotype associated with novel deletions of the PHOX2B gene.
|
Academic Article
|
Monozygotic twins discordant for ROHHAD phenotype.
|
Academic Article
|
Therapeutic strategies in fragile X syndrome: dysregulated mGluR signaling and beyond.
|
Academic Article
|
Widespread non-central nervous system organ pathology in fragile X premutation carriers with fragile X-associated tremor/ataxia syndrome and CGG knock-in mice.
|
Academic Article
|
Effect of Anticoagulants on Amyloid ?-Protein Precursor and Amyloid Beta Levels in Plasma.
|
Academic Article
|
Rapid-onset obesity with hypothalamic dysfunction, hypoventilation, and autonomic dysregulation: analysis of hypothalamic and autonomic candidate genes.
|
Academic Article
|
Altered zinc transport disrupts mitochondrial protein processing/import in fragile X-associated tremor/ataxia syndrome.
|
Academic Article
|
Autonomic regulation in fragile X syndrome.
|
Academic Article
|
Targeted treatments for fragile X syndrome.
|
Academic Article
|
Mutations in prickle orthologs cause seizures in flies, mice, and humans.
|
Academic Article
|
Reliability of eye tracking and pupillometry measures in individuals with fragile X syndrome.
|
Academic Article
|
Epigenetic modification of the FMR1 gene in fragile X syndrome is associated with differential response to the mGluR5 antagonist AFQ056.
|
Academic Article
|
Comparison of PHOX2B testing methods in the diagnosis of congenital central hypoventilation syndrome and mosaic carriers.
|
Academic Article
|
Seizures in fragile X syndrome: characteristics and comorbid diagnoses.
|
Academic Article
|
Open-label add-on treatment trial of minocycline in fragile X syndrome.
|
Academic Article
|
Fragile X: leading the way for targeted treatments in autism.
|
Academic Article
|
Aging in fragile X syndrome.
|
Academic Article
|
Evidence of mitochondrial dysfunction in fragile X-associated tremor/ataxia syndrome.
|
Academic Article
|
Array-based FMR1 sequencing and deletion analysis in patients with a fragile X syndrome-like phenotype.
|
Academic Article
|
[ATS clinical policy statement: congenital central hypoventilation syndrome. Genetic basis, diagnosis and management].
|
Academic Article
|
Update on Kleefstra Syndrome.
|
Academic Article
|
Clinical involvement in daughters of men with fragile X-associated tremor ataxia syndrome.
|
Academic Article
|
An official ATS clinical policy statement: Congenital central hypoventilation syndrome: genetic basis, diagnosis, and management.
|
Academic Article
|
Congenital central hypoventilation syndrome from past to future: model for translational and transitional autonomic medicine.
|
Academic Article
|
Sudden infant death syndrome (SIDS) in African Americans: polymorphisms in the gene encoding the stress peptide pituitary adenylate cyclase-activating polypeptide (PACAP).
|
Academic Article
|
Later-onset congenital central hypoventilation syndrome due to a heterozygous 24-polyalanine repeat expansion mutation in the PHOX2B gene.
|
Academic Article
|
HTR2A variation and sudden infant death syndrome: a case-control analysis.
|
Academic Article
|
Congenital central hypoventilation syndrome (CCHS) and sudden infant death syndrome (SIDS): kindred disorders of autonomic regulation.
|
Academic Article
|
Genetic variation in the HTR1A gene and sudden infant death syndrome.
|
Academic Article
|
Rapid-onset obesity with hypothalamic dysfunction, hypoventilation, and autonomic dysregulation presenting in childhood.
|
Academic Article
|
Sudden infant death syndrome: rare mutation in the serotonin system FEV gene.
|
Academic Article
|
Vagal and sympathetic heart rate and blood pressure control in adult onset PHOX2B mutation-confirmed congenital central hypoventilation syndrome.
|
Academic Article
|
CGG repeat length correlates with age of onset of motor signs of the fragile X-associated tremor/ataxia syndrome (FXTAS).
|
Academic Article
|
Sudden Infant Death Syndrome: review of implicated genetic factors.
|
Academic Article
|
Congenital central hypoventilation syndrome: PHOX2B mutations and phenotype.
|
Academic Article
|
PHOX2B mutation-confirmed congenital central hypoventilation syndrome: presentation in adulthood.
|
Academic Article
|
Sudden infant death syndrome: Case-control frequency differences in paired like homeobox (PHOX) 2B gene.
|
Academic Article
|
Nicotine metabolizing genes GSTT1 and CYP1A1 in sudden infant death syndrome.
|
Academic Article
|
3' UTR polymorphism of the serotonin transporter gene and sudden infant death syndrome: haplotype analysis.
|
Academic Article
|
In pursuit (and discovery) of a genetic basis for congenital central hypoventilation syndrome.
|
Academic Article
|
Adult identified with congenital central hypoventilation syndrome--mutation in PHOX2b gene and late-onset CHS.
|
Academic Article
|
Genetics of congenital central hypoventilation syndrome: lessons from a seemingly orphan disease.
|
Academic Article
|
Fragile X premutation carriers: characteristic MR imaging findings of adult male patients with progressive cerebellar and cognitive dysfunction.
|
Academic Article
|
Platelet serotonin studies in hyperserotonemic relatives of children with autistic disorder.
|
Academic Article
|
Neurological and endocrine phenotypes of fragile X carrier women.
|
Academic Article
|
Further characterization of ATP6V0A2-related autosomal recessive cutis laxa.
|
Academic Article
|
A comparative study of the performance of individuals with fragile X syndrome and Fmr1 knockout mice on Hebb-Williams mazes.
|
Academic Article
|
A review of fragile X premutation disorders: expanding the psychiatric perspective.
|
Academic Article
|
A pilot open label, single dose trial of fenobam in adults with fragile X syndrome.
|
Academic Article
|
Advances in the treatment of fragile X syndrome.
|
Academic Article
|
A comparative neuropsychological test battery differentiates cognitive signatures of Fragile X and Down syndrome.
|
Academic Article
|
Prepulse inhibition in fragile X syndrome: feasibility, reliability, and implications for treatment.
|
Academic Article
|
Open-label treatment trial of lithium to target the underlying defect in fragile X syndrome.
|
Academic Article
|
Early-phase ERK activation as a biomarker for metabolic status in fragile X syndrome.
|
Academic Article
|
Characterization of potential outcome measures for future clinical trials in fragile X syndrome.
|
Academic Article
|
Recommendations from multi-disciplinary focus groups on cascade testing and genetic counseling for fragile X-associated disorders.
|
Academic Article
|
Aging in individuals with the FMR1 mutation.
|
Academic Article
|
Psychopharmacology in fragile X syndrome--present and future.
|
Academic Article
|
Fragile X premutation tremor/ataxia syndrome: molecular, clinical, and neuroimaging correlates.
|
Academic Article
|
Epilepsy in fragile X syndrome.
|
Academic Article
|
Cognitive and visual processing skills and their relationship to mutation size in full and premutation female fragile X carriers.
|
Academic Article
|
Overexpression of fragile X gene (FMR-1) transcripts increases cAMP production in neural cells.
|
Academic Article
|
Carnitine levels and the ketogenic diet.
|
Academic Article
|
Preferential beta-hexosaminidase (Hex) A (alpha beta) formation in the absence of beta-Hex B (beta beta) due to heterozygous point mutations present in beta-Hex beta-chain alleles of a motor neuron disease patient.
|
Academic Article
|
Neuromodulator-mediated phosphorylation of specific proteins in a neurotumor hybrid cell line (NCB-20).
|
Academic Article
|
Differential regulation of multiple neuroreceptors in a somatic cell hybrid by inhibitors of glycoprotein processing.
|
Academic Article
|
Possible role of gangliosides in regulating an adenylate cyclase-linked 5-hydroxytryptamine (5-HT1) receptor.
|
Academic Article
|
Evidence for [D-Ala2,D-Leu5]enkephalin-induced supersensitivity to 5-hydroxytryptamine in a neurotumor x brain hybrid cell line (NCB-20).
|
Academic Article
|
Specific receptor-mediated inhibition of cyclic AMP synthesis by dopamine in a neuroblastoma X brain hybrid cell line NCB-20.
|
Academic Article
|
Gangliosides as modulators of the coupling of neurotransmitters to adenylate cyclase.
|
Academic Article
|
Characterization of an adenylate cyclase-linked serotonin (5-HT1) receptor in a neuroblastoma X brain explant hybrid cell line (NCB-20).
|
Academic Article
|
Modulation of an adenylate cyclase-linked serotonin (5-HT) receptor system in a neuroblastoma x brain explant hybrid cell line (NCB-20) by opiates, prostaglandins, and alpha 2-adrenergic agonists.
|
Academic Article
|
Cyclic AMP metabolism in fragile X syndrome.
|
Academic Article
|
Fragile X syndrome in a normal IQ male with learning and emotional problems.
|
Academic Article
|
X-linked pachygyria and agenesis of the corpus callosum: evidence for an X chromosome lissencephaly locus.
|
Academic Article
|
Demonstration of abnormal cyclic AMP production in platelets from patients with fragile X syndrome.
|
Academic Article
|
Reduced cyclic AMP production in fragile X syndrome: cytogenetic and molecular correlations.
|
Academic Article
|
Mosaic trisomy 16 ascertained through amniocentesis: evaluation of 11 new cases.
|
Academic Article
|
X-linked lissencephaly with absent corpus callosum and ambiguous genitalia.
|
Academic Article
|
Prenatal testing for late infantile neuronal ceroid lipofuscinosis.
|
Academic Article
|
Bruising and the ketogenic diet: evidence for diet-induced changes in platelet function.
|
Academic Article
|
Filamin A mutations cause periventricular heterotopia with Ehlers-Danlos syndrome.
|
Academic Article
|
Development of genomic reference materials for Huntington disease genetic testing.
|
Academic Article
|
Long-Term Treatment of Niemann-Pick Type C1 Disease With Intrathecal 2-Hydroxypropyl-?-Cyclodextrin.
|
Academic Article
|
Utility of the Hebb-Williams Maze Paradigm for Translational Research in Fragile X Syndrome: A Direct Comparison of Mice and Humans.
|
Academic Article
|
Health Profiles of Mosaic Versus Non-mosaic FMR1 Premutation Carrier Mothers of Children With Fragile X Syndrome.
|
Academic Article
|
ASFMR1 splice variant: A predictor of fragile X-associated tremor/ataxia syndrome.
|
Academic Article
|
Diagnosis of niemann-pick C1 by measurement of bile acid biomarkers in archived newborn dried blood spots.
|
Academic Article
|
Cognitive function impacts gait, functional mobility and falls in fragile X-associated tremor/ataxia syndrome.
|
Academic Article
|
The Corpus Callosum Splenium Sign in Fragile X-Associated Tremor Ataxia Syndrome.
|
Academic Article
|
Volumetric Analysis of the Basal Ganglia and Cerebellar Structures in Patients with Phelan-McDermid Syndrome.
|
Academic Article
|
Mavoglurant in Fragile X Syndrome: Results of two open-label, extension trials in adults and adolescents.
|
Academic Article
|
Clinical Development of Targeted Fragile X Syndrome Treatments: An Industry Perspective.
|
Academic Article
|
Best Practices in Fragile X Syndrome Treatment Development.
|
Academic Article
|
Effects of mavoglurant on visual attention and pupil reactivity while viewing photographs of faces in Fragile X Syndrome.
|
Academic Article
|
Congenital central hypoventilation syndrome: Severe disease caused by co-occurrence of two PHOX2B variants inherited separately from asymptomatic family members.
|
Academic Article
|
Voice of People with Fragile X Syndrome and Their Families: Reports from a Survey on Treatment Priorities.
|
Academic Article
|
BCAP31 Mutation Causing a Syndrome of Congenital Dystonia, Facial Dysorphism and Central Hypomyelination Discovered Using Exome Sequencing.
|
Academic Article
|
Clinimetric Properties of the Fragile X-associated Tremor Ataxia Syndrome Rating Scale.
|
Academic Article
|
Expression and Characterization of Human Fragile X Mental Retardation Protein Isoforms and Interacting Proteins in Human Cells.
|
Academic Article
|
Double-blind, randomized, placebo-controlled study of trofinetide in pediatric Rett syndrome.
|
Academic Article
|
Discovering translational biomarkers in neurodevelopmental disorders.
|
Academic Article
|
Altered steady state and activity-dependent de novo protein expression in fragile X syndrome.
|
Academic Article
|
Emerging pharmacological therapies in fragile X syndrome and autism.
|
Academic Article
|
Mutation update for the SATB2 gene.
|
Academic Article
|
Preventive care services and health behaviors in children with fragile X syndrome.
|
Academic Article
|
N-acyl-O-phosphocholineserines: structures of a novel class of lipids that are biomarkers for Niemann-Pick C1 disease.
|
Academic Article
|
Improving the Diagnosis of Autism Spectrum Disorder in Fragile X Syndrome by Adapting the Social Communication Questionnaire and the Social Responsiveness Scale-2.
|
Academic Article
|
Language processing skills linked to FMR1 variation: A study of gaze-language coordination during rapid automatized naming among women with the FMR1 premutation.
|
Academic Article
|
Data-driven phenotype discovery of FMR1 premutation carriers in a population-based sample.
|
Academic Article
|
Pharmacologic Interventions for Irritability, Aggression, Agitation and Self-Injurious Behavior in Fragile X Syndrome: An Initial Cross-Sectional Analysis.
|
Academic Article
|
Toilet Training in Fragile X Syndrome.
|
Academic Article
|
Vocabulary comprehension in adults with fragile X syndrome (FXS).
|
Academic Article
|
Physiological regulation and social-emotional processing in female carriers of the FMR1 premutation.
|
Academic Article
|
Neuropsychiatric decompensation in adolescents and adults with Phelan-McDermid syndrome: a systematic review of the literature.
|
Academic Article
|
Inhibition deficits are modulated by age and CGG repeat length in carriers of the FMR1 premutation allele who are mothers of children with fragile X syndrome.
|
Academic Article
|
Open-label pilot clinical trial of citicoline for fragile X-associated tremor/ataxia syndrome (FXTAS).
|
Academic Article
|
Application of N-palmitoyl-O-phosphocholineserine for diagnosis and assessment of response to treatment in Niemann-Pick type C disease.
|
Academic Article
|
Neurodevelopmental Characterization of Young Children Diagnosed with Niemann-Pick Disease, Type C1.
|
Academic Article
|
Validation of the NIH Toolbox Cognitive Battery in intellectual disability.
|
Academic Article
|
Diffusion Tensor Imaging Abnormalities in the Uncinate Fasciculus and Inferior Longitudinal Fasciculus in Phelan-McDermid Syndrome.
|
Academic Article
|
Expressive language sampling as a source of outcome measures for treatment studies in fragile X syndrome: feasibility, practice effects, test-retest reliability, and construct validity.
|
Academic Article
|
TECPR2 mutation-associated respiratory dysregulation: more than central apnea.
|
Academic Article
|
Correction to: Expressive language sampling as a source of outcome measures for treatment studies in fragile X syndrome: feasibility, practice effects, test-retest reliability, and construct validity.
|
Academic Article
|
Language across the Lifespan in Fragile X Syndrome: Characteristics and Considerations for Assessment.
|
Academic Article
|
Examination of Correlates to Health-Related Quality of Life in Individuals with Fragile X Syndrome.
|
Academic Article
|
Anesthetic management of pediatric patients with Niemann-Pick disease type C for intrathecal 2-hydroxypropyl-?-cyclodextrin injection.
|
Academic Article
|
Psychometric Study of the Social Responsiveness Scale in Phelan-McDermid Syndrome.
|
Academic Article
|
Fragile X Gray Zone Alleles Are Associated With Signs of Parkinsonism and Earlier Death.
|
Academic Article
|
Normative database of spatiotemporal gait parameters using inertial sensors in typically developing children and young adults.
|
Academic Article
|
A Double-Blind, Randomized, Placebo-Controlled Clinical Study of Trofinetide in the Treatment of Fragile X Syndrome.
|
Academic Article
|
Intracerebroventricular Cerliponase Alfa for Neuronal Ceroid Lipofuscinosis Type 2 Disease: Clinical Practice Considerations From US Clinics.
|
Academic Article
|
Optimization of Protocols for Detection of De Novo Protein Synthesis in Whole Blood Samples via Azide-Alkyne Cycloaddition.
|
Academic Article
|
Response to Placebo in Fragile X Syndrome Clinical Trials: An Initial Analysis.
|
Academic Article
|
A Genotype-Phenotype Study of High-Resolution FMR1 Nucleic Acid and Protein Analyses in Fragile X Patients with Neurobehavioral Assessments.
|
Academic Article
|
Prodromal Markers of Upper Limb Deficits in FMR1 Premutation Carriers and Quantitative Outcome Measures for Future Clinical Trials in Fragile X-associated Tremor/Ataxia Syndrome.
|
Academic Article
|
Soy-Based Infant Formula is Associated with an Increased Prevalence of Comorbidities in Fragile X Syndrome.
|
Academic Article
|
The Effects of Dual Task Cognitive Interference and Fast-Paced Walking on Gait, Turns, and Falls in Men and Women with FXTAS.
|
Academic Article
|
Person Ability Scores as an Alternative to Norm-Referenced Scores as Outcome Measures in Studies of Neurodevelopmental Disorders.
|
Academic Article
|
Development of Neural Response to Novel Sounds in Fragile X Syndrome: Potential Biomarkers.
|
Academic Article
|
Reduced Expression of Cerebral Metabotropic Glutamate Receptor Subtype 5 in Men with Fragile X Syndrome.
|
Academic Article
|
Application of a glycinated bile acid biomarker for diagnosis and assessment of response to treatment in Niemann-pick disease type C1.
|
Academic Article
|
A Unique Visual Attention Profile Associated With the FMR1 Premutation.
|
Academic Article
|
Diagnostic profile of the AmplideX Fragile X Dx and Carrier Screen Kit for diagnosis and screening of fragile X syndrome and other FMR1-related disorders.
|
Academic Article
|
Spoken language outcome measures for treatment studies in Down syndrome: feasibility, practice effects, test-retest reliability, and construct validity of variables generated from expressive language sampling.
|
Academic Article
|
Cell-type-specific profiling of human cellular models of fragile X syndrome reveal PI3K-dependent defects in translation and neurogenesis.
|
Academic Article
|
Niemann-Pick Disease, Type C: Diagnosis, Management and Disease-Targeted Therapies in Development.
|
Academic Article
|
Shifted phase of EEG cross-frequency coupling in individuals with Phelan-McDermid syndrome.
|
Academic Article
|
Emergence of Developmental Delay in Infants and Toddlers With an FMR1 Mutation.
|
Academic Article
|
Inhibition of phosphodiesterase-4D in adults with fragile X syndrome: a randomized, placebo-controlled, phase 2 clinical trial.
|
Academic Article
|
Paired-like homeobox gene (PHOX2B) nonpolyalanine repeat expansion mutations (NPARMs): genotype-phenotype correlation in congenital central hypoventilation syndrome (CCHS).
|
Academic Article
|
Clinical trial strategies for rare neurodevelopmental disorders: challenges and opportunities.
|
Academic Article
|
Identifying susceptibility genes for primary ovarian insufficiency on the high-risk genetic background of a fragile X premutation.
|
Academic Article
|
Stress and genetics influence hair cortisol in FMR1 premutation carrier mothers of children with fragile X syndrome.
|
Academic Article
|
Characterization of the Cerebrospinal Fluid Proteome in Patients with Fragile X-Associated Tremor/Ataxia Syndrome.
|
Academic Article
|
A novel measure of matching categories for early development: Item creation and pilot feasibility study.
|
Academic Article
|
Mild Neurological Signs in FMR1 Premutation Women in an Unselected Community-Based Cohort.
|
Academic Article
|
Tremorography in fragile X-associated tremor/ataxia syndrome, Parkinson's disease and essential tremor.
|
Academic Article
|
The Phenotypic Profile Associated With the FMR1 Premutation in Women: An Investigation of Clinical-Behavioral, Social-Cognitive, and Executive Abilities.
|
Academic Article
|
Normative database of postural sway measures using inertial sensors in typically developing children and young adults.
|
Academic Article
|
Is FMR1 CGG Repeat Number Polymorphism Associated With Phenotypic Variation in the General Population? Report From a Cohort of 5,499 Adults.
|
Academic Article
|
Correction to: Characterization of the Cerebrospinal Fluid Proteome in Patients with Fragile X-Associated Tremor/Ataxia Syndrome.
|
Academic Article
|
Strong evidence for genotype-phenotype correlations in Phelan-McDermid syndrome: results from the developmental synaptopathies consortium.
|
Academic Article
|
Symptoms of Autism Spectrum Disorder in Individuals with Down Syndrome.
|
Academic Article
|
Gaboxadol in Fragile X Syndrome: A 12-Week Randomized, Double-Blind, Parallel-Group, Phase 2a Study.
|
Academic Article
|
Parent-reported measure of repetitive behavior in Phelan-McDermid syndrome.
|
Academic Article
|
Psychotropic Drug Treatment Patterns in Persons with Fragile X Syndrome.
|
Academic Article
|
The CD22-IGF2R interaction is a therapeutic target for microglial lysosome dysfunction in Niemann-Pick type C.
|
Academic Article
|
De novo variants in H3-3A and H3-3B are associated with neurodevelopmental delay, dysmorphic features, and structural brain abnormalities.
|
Academic Article
|
Sleep problems in fragile X syndrome: Cross-sectional analysis of a large clinic-based cohort.
|
Academic Article
|
Consistently High Agreement Between Independent Raters of Niemann-Pick Type C1 Clinical Severity Scale in Phase 2/3 Trial.
|
Academic Article
|
Seizures in Fragile X Syndrome: Associations and Longitudinal Analysis of a Large Clinic-Based Cohort.
|
Academic Article
|
The association between mosaicism type and cognitive and behavioral functioning among males with fragile X syndrome.
|
Academic Article
|
Design and outcome measures of LAVENDER, a phase 3 study of trofinetide for Rett syndrome.
|
Academic Article
|
Fragile X Syndrome: Supportive Treatment, Unmet Needs, and Paths to Novel Interventions and Disease-Targeted Therapies.
|
Academic Article
|
Independent evaluation of the harvard automated processing pipeline for Electroencephalography 1.0 using multi-site EEG data from children with Fragile X Syndrome.
|
Academic Article
|
Verbal inhibition declines among older women with high FMR1 premutation expansions: A prospective study.
|
Academic Article
|
Fragile X Mental Retardation Protein and Cerebral Expression of Metabotropic Glutamate Receptor Subtype 5 in Men with Fragile X Syndrome: A Pilot Study.
|
Academic Article
|
Gene-based therapeutics for rare genetic neurodevelopmental psychiatric disorders.
|
Academic Article
|
Analysis of a Repetitive Language Coding System: Comparisons between Fragile X Syndrome, Autism, and Down Syndrome.
|
Academic Article
|
Disease-Targeted Treatment Translation in Fragile X Syndrome as a Model for Neurodevelopmental Disorders.
|
Academic Article
|
Observable Symptoms of Anxiety in Individuals with Fragile X Syndrome: Parent and Caregiver Perspectives.
|
Academic Article
|
Low Risk Profile of Long-Term Repeated Lumbar Puncture for Intrathecal Delivery of 2-Hydroxypropyl-Beta-Cyclodextrin in Patients With Niemann-Pick Type C.
|
Academic Article
|
Expressive language sampling and outcome measures for treatment trials in fragile X and down syndromes: composite scores and psychometric properties.
|
Academic Article
|
Trofinetide for the treatment of Rett syndrome: a randomized phase 3 study.
|
Academic Article
|
Study design challenges and strategies in clinical trials for rare diseases: Lessons learned from pantothenate kinase-associated neurodegeneration.
|
Academic Article
|
The association between expressive language skills and adaptive behavior in individuals with Down syndrome.
|
Academic Article
|
A randomized, controlled trial of ZYN002 cannabidiol transdermal gel in children and adolescents with fragile X syndrome (CONNECT-FX).
|
Academic Article
|
DDX3X Syndrome: Summary of Findings and Recommendations for Evaluation and Care.
|
Academic Article
|
Sensitivity of the NIH Toolbox to Detect Cognitive Change in Individuals With Intellectual and Developmental Disability.
|
Academic Article
|
Neurofilament light chain in cerebrospinal fluid as a novel biomarker in evaluating both clinical severity and therapeutic response in Niemann-Pick disease type C1.
|
Academic Article
|
Atypical vocal quality in women with the FMR1 premutation: an indicator of impaired sensorimotor control.
|
Academic Article
|
Antisense oligonucleotide rescue of CGG expansion-dependent FMR1 mis-splicing in fragile X syndrome restores FMRP.
|
Academic Article
|
Updated consensus guidelines on the management of Phelan-McDermid syndrome.
|
Academic Article
|
FMR1 CGG Repeats and Stress Influence Self-Reported Cognitive Functioning in Mothers.
|
Academic Article
|
Descriptive analysis of seizures and comorbidities associated with fragile X syndrome.
|
Academic Article
|
Lymphocytic Extracellular Signal-Regulated Kinase Dysregulation in Autism Spectrum Disorder.
|
Academic Article
|
The comparison of expressed emotion of parents of individuals with fragile X syndrome to other intellectual disabilities.
|
Academic Article
|
Identification of cerebral spinal fluid protein biomarkers in Niemann-Pick disease, type C1.
|
Academic Article
|
The effect of college degree attainment on neurodegenerative symptoms in genetically at-risk women.
|
Academic Article
|
Large 22q13.3 deletions perturb peripheral transcriptomic and metabolomic profiles in Phelan-McDermid syndrome.
|
Academic Article
|
Associations Among Sex, Cognitive Ability, and Autism Symptoms in Individuals with Down Syndrome.
|
Academic Article
|
Effects of AFQ056 on language learning in fragile X syndrome.
|
Academic Article
|
Mortality in Women across the FMR1 CGG Repeat Range: The Neuroprotective Effect of Higher Education.
|
Academic Article
|
Enabling endpoint development for interventional clinical trials in individuals with Angelman syndrome: a prospective, longitudinal, observational clinical study (FREESIAS).
|
Academic Article
|
Elevated cerebrospinal fluid ubiquitin C-terminal hydrolase-L1 levels correlate with phenotypic severity and therapeutic response in Niemann-Pick disease, type C1.
|
Academic Article
|
Health Effects of Sleep Quality in Premutation Carrier Mothers of Individuals With Fragile X Syndrome.
|
Academic Article
|
Delineating Repetitive Behavior Profiles across the Lifespan in Fragile X Syndrome.
|
Academic Article
|
Low normal FMR1 genotype in older adult women: Psychological well-being and motor function.
|
Academic Article
|
Emerging Therapeutic Strategies for Fragile X Syndrome: Q&A.
|
Academic Article
|
Digital gait markers to potentially distinguish fragile X-associated tremor/ataxia syndrome, Parkinson's disease, and essential tremor.
|
Concept
|
Social Communication Disorder
|
Concept
|
Genetic Background
|
Concept
|
Orexins
|
Concept
|
Intersectoral Collaboration
|
Concept
|
Walk Test
|
Concept
|
Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha
|
Concept
|
Walking Speed
|
Concept
|
2-Hydroxypropyl-beta-cyclodextrin
|